Gemcitabine and Oxaliplatin for Hepatocellular Carcinoma With Platelet Counts Greater Than 100,000 Per Microliter

NCT00250822 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

11

Enrollment

OTHER

Sponsor class

Conditions

Liver Cancer

Interventions

DRUG: Gemcitabine and Oxaliplatin

Sponsor

New Mexico Cancer Research Alliance